Getinge Hisse

Getinge EBITDA

Getinge (GETI B.ST) öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 22 Ağu 2026 itibarıyla 5,47 Md SEK dir. Önceki yılda, EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) 5,62 Md SEK idi — -2,65% (daha düşük) bir değişiklik.

EBITDA

5,47 MdSEK

YoY

-2,65%

Son güncelleme:

Getinge öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 5,47 Md SEK dir. Getinge öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2025 5,62 Md SEK idi. %-2,65 daha düşük önceki yıla kıyasla azalmaktadır.

Getinge EBITDA Tarihçesi

  • 3 yıl

  • 10 yıl

  • 25 Yıl

  • Maks.

EBITDA
Date
EBITDA
1 Oca 2018
725,00 M SEK
1 Oca 2019
3,94 Md SEK
1 Oca 2020
6,41 Md SEK
1 Oca 2021
5,47 Md SEK
1 Oca 2022
4,96 Md SEK
1 Oca 2023
5,19 Md SEK
1 Oca 2024
5,62 Md SEK
1 Oca 2025
5,47 Md SEK
Getinge EBITDA Tarihçesi
YILEBITDAYoY
5,47 MdSEK-2,65%
5,62 MdSEK+8,41%
5,19 MdSEK+4,60%
4,96 MdSEK-9,36%
5,47 MdSEK-14,69%
6,41 MdSEK+62,59%
3,94 MdSEK+443,86%
725,00 MSEK-77,69%
3,25 MdSEK-11,66%
3,68 MdSEK-23,08%
4,78 MdSEK
Access this data via the Eulerpool API

Getinge Hisse senedi analizi

Getinge ne yapar? Getinge AB is a globally leading company that offers innovative solutions and products for the healthcare industry. The company was founded in Sweden in 1904 and has since had a long history in the medical technology industry. Getinge AB is known for its leading position in the field of medical equipment, including autoclaves, sterilizers, washer-disinfectors, and ventilators. The business model of Getinge AB is focused on the needs of customers in the healthcare sector. The company operates five business areas: Acute Care Therapies, Infection Control, Extended Care, Life Science, and Surgical Workflows. Each of these business areas focuses on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers innovative and high-quality products and services worldwide. The company promotes continuous innovation and aims to leverage the potential of cutting-edge technologies in the market to develop solutions that improve the lives of patients and healthcare professionals. Various divisions and products - Acute Care Therapies: One of Getinge AB's main products in the Acute Care Therapies area is extracorporeal membrane oxygenation machines (ECMO). These systems are used to support patients with respiratory failure. Another important product line is the Intra-Aortic Balloon Pump (IABP), which is used to support patients with heart failure or cardiogenic shock. - Infection Control: In the Infection Control area, Getinge AB focuses on developing products to control infections that can be caused by hospital environments and medical instruments. This includes sterilization and disinfection devices, as well as cleaning and disinfection agents. - Extended Care: The Extended Care business area offers products and solutions for non-acute patient care. The company focuses on offering innovative products and services that contribute to improving the quality of care and reducing costs. This includes products such as patient beds, mattresses, and assistive devices. - Life Science: In the Life Science area, Getinge AB offers products and services for the biopharmaceutical industry and for research and development. The company specializes in the development of cleanroom technology, which helps make the production of medications safer and more efficient. - Surgical Workflows: The Surgical Workflows business area focuses on optimizing surgical workflows and increasing efficiency. Getinge AB offers products and services such as operating tables, anesthesia and monitoring systems, and wound care products. In summary, Getinge AB has a long history in the medical technology industry and is a leading company in the field. The company operates five business areas that focus on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers worldwide innovative and high-quality products and services. The product range includes a wide range of innovative medical technology products, including autoclaves, sterilizers, washer-disinfectors, ventilators, cleaning and disinfection agents, and other medical technology products. Getinge, Eulerpool'daki en popüler şirketlerden biridir.

Getinge hisse senedi hakkında sık sorulan sorular

Getinge şirketinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 yılında 5,47 Md SEK.

Getinge öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 5,62 Md SEK değerinden 5,47 Md SEK değerine değişmiş ve bu %-2,65 değişimi temsil etmektedir. Değer önceki yıldan daha düşük dir.

Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) öğesinin Getinge değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

EBITDA, finansal yapı, vergi ortamı ve nakit olmayan amortisman giderleri etkisinden önceki işletme performansını ölçer.

EBITDA = EBIT + Amortisman

EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin SEK, yatırımcılar için kilit bir faktördür. Bu metrikte yapılan değişiklikler temel faktörlerin iyileşmesini veya kötüleşmesini gösterebilir ve hisse senedi fiyatını doğrudan etkiler. Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin Getinge değerini tarihsel olarak ve gerçek zamanlı olarak takip edebilirsiniz.

Access this data via the Eulerpool API

Gelir Tablosu — Getinge

Tüm Kilit Metrikler — Getinge